Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

China flag China · Delayed Price · Currency is CNY
3.530
-0.110 (-3.02%)
Jun 11, 2026, 3:04 PM CST
Market Cap2.40B -50.2%
Revenue (ttm)283.34M -9.2%
Net Income-133.66M
EPS-0.20
Shares Out 659.74M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,694,504
Open4.040
Previous Close3.640
Day's Range3.460 - 4.040
52-Week Range3.460 - 11.670
Beta-0.00
Analystsn/a
Price Targetn/a
Earnings DateAug 24, 2026

About SHE:002581

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. The company is involved in the chemical raw materials, chemical product manufacturing, and biopharmaceutical manufacturing; production and sales of medicines. It also offers operating chemical products, such as trimethyl ester and triethyl ester. The company was founded in 2000 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd. [Read more]

Sector Healthcare
Founded 2000
Employees 476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002581
Full Company Profile

Financial Performance

In 2025, SHE:002581's revenue was 274.81 million, a decrease of -23.75% compared to the previous year's 360.41 million. Losses were -116.28 million, -15.32% less than in 2024.

Financial Statements